At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Optimizing Care for Older Adults With Back Pain and Depression
In Brief
A Phase 4 clinical trial evaluating Higher-dose venlafaxine, Supportive management, and 1 other intervention for Depression and Back Pain. Completed, enrolled 263 participants across 1 site.
Detailed Summary
The primary question addressed by this study is: Using a stepped care approach in primary care, what is the value of the combination of an antidepressant medication (Venlafaxine) and psychotherapy for seniors living with depression and chronic lower back pain when treatment with a low-dose of venlafaxine and supportive management (SM) has led to only a partial or non-response?
Study Details
Timeline
Interventions
Dosing of venlafaxine will range from 187.5-300 mg/day.
Supportive management encourages participants to take the medication and manages any treatment-emergent side effects. Ten sessions will be delivered over the course of 14 weeks.
PST-DP will be delivered over the course of 10 sessions over 14 weeks. Along with teaching the participant 7 steps of problem solving, PST-DP also includes a medication support and management component.